Leal Therapeutics
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$45M
Leal Therapeutics is a biotechnology company developing treatments for central nervous system disorders, focusing on amyotrophic lateral sclerosis (ALS) and schizophrenia.
Focus Areas
Biotechnology
Central Nervous System
ALS
Schizophrenia
Human Trials
Investors
